查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881436

藥物篩檢市場－全球產業規模、佔有率、趨勢、機會和預測，按產品和服務、樣本類型、最終用戶、地區和競爭格局分類，2020-2030年預測

Drug Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Sample Type, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球藥物篩檢市場規模為55.6億美元，預計2030年將以5.3%的複合年成長率成長至75.8億美元。全球藥物篩檢市場涵蓋用於檢測生物樣本中非法物質、管制藥物及其代謝物的檢測解決方案的開發、生產和分銷。該市場成長的主要促進因素是全球藥物濫用問題日益嚴重，以及包括工作場所和交通運輸在內的各個領域對藥物檢測的嚴格監管要求。

市場概覽
預測期 2026-2030
2024年市場規模 55.6億美元
2030年市場規模 75.8億美元
2025-2030年複合年成長率 5.3%
成長最快的細分市場 尿液樣本
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球藥物篩選市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務分類（藥物篩檢產品、分析儀器、快速檢測設備、口腔液檢測設備、耗材、藥物篩檢服務）
    • 依樣本類型（尿液樣本、呼氣樣本、口腔液樣本、毛髮樣本、其他樣本）
    • 按最終使用者分類（藥物檢測實驗室、工作場所、刑事司法和執法機構、醫院、戒毒治療中心、個人使用者、疼痛管理中心、學校和學院）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美藥物篩檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲藥物篩檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區藥物篩選市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲藥物篩檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲藥物篩檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球藥物篩選市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Quest Diagnostics Inc.
  • Heska Corporation
  • Thermo Fisher Scientific, Inc.
  • Alfa Scientific Designs, Inc.
  • OraSure Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • MPD Inc.
  • Shimadzu Corporation
  • Lifeloc Technologies, Inc.
  • Dragerwerk AG & Co. KGaA
  • Premier Biotech, Inc.
  • Omega Laboratories, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 20996

The Global Drug Screening Market, valued at USD 5.56 Billion in 2024, is projected to experience a CAGR of 5.3% to reach USD 7.58 Billion by 2030. The global drug screening market is defined by the development, production, and distribution of testing solutions designed to detect illicit substances, controlled medications, and their metabolites in biological samples. This market's growth is primarily driven by the escalating global incidence of substance abuse and stringent regulatory mandates for drug testing across diverse sectors, including workplaces and transportation.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.56 Billion
Market Size 2030USD 7.58 Billion
CAGR 2025-20305.3%
Fastest Growing SegmentUrine Samples
Largest MarketNorth America

Key Market Drivers

The global drug screening market is significantly influenced by the escalating rates of substance abuse worldwide. As illicit drug use continues to rise, there is a corresponding surge in the demand for effective screening solutions across various sectors, including healthcare, workplaces, and criminal justice. This heightened prevalence of drug use necessitates robust detection methods to safeguard public health and maintain societal order. According to the UNODC World Drug Report 2024, the number of people who use drugs globally rose to 292 million in 2022, marking a 20 percent increase over the preceding decade. This trend directly fuels the need for expanded drug testing programs, driving both the volume of tests performed and the innovation required to detect a broader spectrum of substances.

Key Market Challenges

The continuous emergence of novel synthetic drugs and designer substances presents a substantial impediment to the growth of the global drug screening market. These rapidly evolving compounds frequently bypass existing detection methodologies, requiring constant and significant analytical innovation from screening providers. This dynamic landscape compels market participants to dedicate substantial resources to ongoing research and development efforts, increasing operational costs and extending timelines for test kit validation and deployment.

Key Market Trends

Technological advancements are profoundly influencing the global drug screening market by improving test speed, accuracy, and the range of detected substances. Innovations in analytical techniques are crucial, especially as attempts to compromise test integrity rise. The 2024 Quest Diagnostics Drug Testing Index reported tampered drug tests in the general U. S. workforce increased over six-fold in 2023 from the prior year, underscoring the demand for robust screening methods. This drives the development of advanced portable devices and laboratory platforms.

Key Market Players

  • Quest Diagnostics Inc.
  • Heska Corporation
  • Thermo Fisher Scientific, Inc.
  • Alfa Scientific Designs, Inc.
  • OraSure Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • MPD Inc.
  • Shimadzu Corporation
  • Lifeloc Technologies, Inc.
  • Dragerwerk AG & Co. KGaA
  • Premier Biotech, Inc.
  • Omega Laboratories, Inc.

Report Scope:

In this report, the Global Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Screening Market, By Product & Services:

  • Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Drug Screening Service

Drug Screening Market, By Sample Type:

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

Drug Screening Market, By End User:

  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges

Drug Screening Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Drug Screening Market.

Available Customizations:

Global Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Drug Screening Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Services (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service)
    • 5.2.2. By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples)
    • 5.2.3. By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Drug Screening Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Services
    • 6.2.2. By Sample Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Drug Screening Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Sample Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Drug Screening Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Sample Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Drug Screening Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Sample Type
        • 6.3.3.2.3. By End User

7. Europe Drug Screening Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services
    • 7.2.2. By Sample Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Drug Screening Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Sample Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Drug Screening Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Sample Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Drug Screening Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Sample Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Drug Screening Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Sample Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Drug Screening Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Services
        • 7.3.5.2.2. By Sample Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Drug Screening Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services
    • 8.2.2. By Sample Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Drug Screening Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Sample Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Drug Screening Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Sample Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Drug Screening Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Sample Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Drug Screening Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Sample Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Drug Screening Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Sample Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Drug Screening Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services
    • 9.2.2. By Sample Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Drug Screening Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Sample Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Drug Screening Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Sample Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Drug Screening Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Sample Type
        • 9.3.3.2.3. By End User

10. South America Drug Screening Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services
    • 10.2.2. By Sample Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Drug Screening Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Sample Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Drug Screening Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Sample Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Drug Screening Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Sample Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Drug Screening Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Quest Diagnostics Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Heska Corporation
  • 15.3. Thermo Fisher Scientific, Inc.
  • 15.4. Alfa Scientific Designs, Inc.
  • 15.5. OraSure Technologies, Inc.
  • 15.6. F. Hoffmann-La Roche Ltd
  • 15.7. MPD Inc.
  • 15.8. Shimadzu Corporation
  • 15.9. Lifeloc Technologies, Inc.
  • 15.10. Dragerwerk AG & Co. KGaA
  • 15.11. Premier Biotech, Inc.
  • 15.12. Omega Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer